REFERENCES

1. Benjamin EJ, Muntner P, Alonso A, et al. Heart disease and stroke statistics-2019 update: a report from the American Heart Association. Circulation. 2019;139:e56-e528.

2. Levine AR, Simon MA, Gladwin MT. Pulmonary vascular disease in the setting of heart failure with preserved ejection fraction. Trends Cardiovasc Med. 2019;29:207-17.

3. Melenovsky V, Hwang SJ, Lin G, Redfield MM, Borlaug BA. Right heart dysfunction in heart failure with preserved ejection fraction. Eur Heart J. 2014;35:3452-62.

4. van de Veerdonk MC, Kind T, Marcus JT, et al. Progressive right ventricular dysfunction in patients with pulmonary arterial hypertension responding to therapy. J Am Coll Cardiol. 2011;58:2511-9.

5. Borgdorff MA, Bartelds B, Dickinson MG, Steendijk P, Berger RM. A cornerstone of heart failure treatment is not effective in experimental right ventricular failure. Int J Cardiol. 2013;169:183-9.

6. Tykocki NR, Boerman EM, Jackson WF. Smooth muscle ion channels and regulation of vascular tone in resistance arteries and arterioles. Compr Physiol. 2017;7:485-581.

7. Archer SL, Souil E, Dinh-Xuan AT, et al. Molecular identification of the role of voltage-gated K⁺ channels, Kv1.5 and Kv2.1, in hypoxic pulmonary vasoconstriction and control of resting membrane potential in rat pulmonary artery myocytes. J Clin Invest. 1998;101:2319-30.

8. Moudgil R, Michelakis ED, Archer SL. The role of K⁺ channels in determining pulmonary vascular tone, oxygen sensing, cell proliferation, and apoptosis: implications in hypoxic pulmonary vasoconstriction and pulmonary arterial hypertension. Microcirculation. 2006;13:615-32.

9. Ohanyan V, Yin L, Bardakjian R, et al. Requisite role of Kv1.5 channels in coronary metabolic dilation. Circ Res. 2015;117:612-21.

10. Yuan XJ. Voltage-gated K⁺ currents regulate resting membrane potential and [Ca²⁺]_i in pulmonary arterial myocytes. Circ Res. 1995;77:370-8.

11. Vera-Zambrano A, Lago-Docampo M, Gallego N, et al. Novel loss-of-function KCNA5 variants in pulmonary arterial hypertension. Am J Respir Cell Mol Biol. 2023;69:147-58.

12. Dutta S, Sengupta P. Men and mice: relating their ages. Life Sci. 2016;152:244-8.

13. Strait JB, Lakatta EG. Aging-associated cardiovascular changes and their relationship to heart failure. Heart Fail Clin. 2012;8:143-64.

14. Bruns DR, Yusifova M, Marcello NA, Green CJ, Walker WJ, Schmitt EE. The peripheral circadian clock and exercise: lessons from young and old mice. J Circadian Rhythms. 2020;18:7.

15. Yusifov A, Chhatre VE, Zumo JM, et al. Cardiac response to adrenergic stress differs by sex and across the lifespan. Geroscience. 2021;43:1799-813.

16. Razeghi P, Young ME, Alcorn JL, Moravec CS, Frazier OH, Taegtmeyer H. Metabolic gene expression in fetal and failing human heart. Circulation. 2001;104:2923-31.

17. Harrison A, Hatton N, Ryan JJ. The right ventricle under pressure: evaluating the adaptive and maladaptive changes in the right ventricle in pulmonary arterial hypertension using echocardiography (2013 Grover Conference series). Pulm Circ. 2015;5:29-47.

18. Sundaram V, Fang JC. Gastrointestinal and liver issues in heart failure. Circulation. 2016;133:1696-703.

19. Hegemann N, Sang P, Kim JH, et al. Ultrasonographic assessment of pulmonary and central venous congestion in experimental heart failure. Am J Physiol Heart Circ Physiol. 2024;326:H433-40.

20. Haddad F, Doyle R, Murphy DJ, Hunt SA. Right ventricular function in cardiovascular disease, part II: pathophysiology, clinical importance, and management of right ventricular failure. Circulation. 2008;117:1717-31.

21. Post JM, Hume JR, Archer SL, Weir EK. Direct role for potassium channel inhibition in hypoxic pulmonary vasoconstriction. Am J Physiol. 1992;262:C882-90.

22. Yang T, Wathen MS, Felipe A, Tamkun MM, Snyders DJ, Roden DM. K⁺ currents and K⁺ channel mRNA in cultured atrial cardiac myocytes (AT-1 cells). Circ Res. 1994;75:870-8.

23. Tanabe Y, Hatada K, Naito N, et al. Over-expression of Kv1.5 in rat cardiomyocytes extremely shortens the duration of the action potential and causes rapid excitation. Biochem Biophys Res Commun. 2006;345:1116-21.

24. Yang Y, Li J, Lin X, et al. Novel KCNA5 loss-of-function mutations responsible for atrial fibrillation. J Hum Genet. 2009;54:277-83.

25. Kepenek ES, Ozcinar E, Tuncay E, Akcali KC, Akar AR, Turan B. Differential expression of genes participating in cardiomyocyte electrophysiological remodeling via membrane ionic mechanisms and Ca²⁺-handling in human heart failure. Mol Cell Biochem. 2020;463:33-44.

26. Umar S, Lee JH, de Lange E, et al. Spontaneous ventricular fibrillation in right ventricular failure secondary to chronic pulmonary hypertension. Circ Arrhythm Electrophysiol. 2012;5:181-90.

27. Bozkurt B, Ahmad T, Alexander K, et al. HF STATS 2024: heart failure epidemiology and outcomes statistics an updated 2024 report from the heart failure society of America. J Card Fail. 2025;31:66-116.

28. Matsubara H, Suzuki J, Inada M. Shaker-related potassium channel, Kv1.4, mRNA regulation in cultured rat heart myocytes and differential expression of Kv1.4 and Kv1.5 genes in myocardial development and hypertrophy. J Clin Invest. 1993;92:1659-66.

29. Wang Z, Tapa S, Francis Stuart SD, et al. Aging disrupts normal time-of-day variation in cardiac electrophysiology. Circ Arrhythm Electrophysiol. 2020;13:e008093.

30. Kang LS, Kim S, Dominguez JM 2nd, Sindler AL, Dick GM, Muller-Delp JM. Aging and muscle fiber type alter K⁺ channel contributions to the myogenic response in skeletal muscle arterioles. J Appl Physiol. 2009;107:389-98.

31. Humbert M, Sitbon O, Yaïci A, et al. Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension. Eur Respir J. 2010;36:549-55.

32. Lahm T, Frump AL, Albrecht ME, et al. 17β-Estradiol mediates superior adaptation of right ventricular function to acute strenuous exercise in female rats with severe pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol. 2016;311:L375-88.

33. Foppa M, Arora G, Gona P, et al. Right ventricular volumes and systolic function by cardiac magnetic resonance and the impact of sex, age, and obesity in a longitudinally followed cohort free of pulmonary and cardiovascular disease: the framingham heart study. Circ Cardiovasc Imaging. 2016;9:e003810.

34. Flurkey K, Randall PK, Sinha YN, Ermini M, Finch CE. Transient shortening of estrous cycles in aging C57BL/6J mice: effects of spontaneous pseudopregnancy, progesterone, L-dihydroxyphenylalanine, and hydergine. Biol Reprod. 1987;36:949-59.

35. Brener MI, Masoumi A, Ng VG, et al. Invasive right ventricular pressure-volume analysis: basic principles, clinical applications, and practical recommendations. Circ Heart Fail. 2022;15:e009101.

36. Lambert M, Mendes-Ferreira P, Ghigna MR, et al. Kcnk3 dysfunction exaggerates the development of pulmonary hypertension induced by left ventricular pressure overload. Cardiovasc Res. 2021;117:2474-88.